Orazephin®
INDICATION: Antibacterial
Orazephin® CR is an oral version of a widely used intravenous antibiotic Ceftriaxone.

Discover Orazephin®

Overview
Ceftriaxone is currently one of the most important and effective broad spectrum antibiotics used to treat over ten different infectious diseases including meningitis and post-surgical prophylaxis.

Phase
Orazephin® CR is currently in Phase I clinical trial.

US Market ($B USD)
The estimated market for Orazephin® in the United States is $0.75 Billion USD.

Global Market ($B USD)
The estimated market for Orazephin® globally is $1.3 Billion USD.